Sign InBreakout Stocks of Week 26 @ GER
NASDAQ was up last week (week 25) by 2.43% ending at 26,517.93 points after gaining 629.09 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Vaneck Morningstar Developed Markets Dividend Leaders Ucits Etf GER:VDIV. This stock has had a buy signal since Jun 17, 2026 when the price was 52.21€ , but have so far fallen -0.82% to 51.78€. Some other companies are on our watchlist to, among these are Hensoldt AG GER:HAG Carl Zeiss Meditec AG GER:AFX Evotec SE GER:EVT and British American Tobacco p.l.c. GER:BMT which all got a breakout pattern emerging.
| Date | Company | Price | Week 26 |
|---|---|---|---|
| Vaneck Morningstar Developed Markets Dividend Lead... | 51.78€ | 51.85€ | 0.135% |
| Hensoldt Ag | 72.46€ | 64.90€ | -10.43% |
| Carl Zeiss Meditec Ag | 24.94€ | 27.30€ | 9.46% |
| Evotec Se | 4.63€ | 4.91€ | 5.96% |
| British American Tobacco P.l.c. | 50.28€ | 55.20€ | 9.79% |
Vaneck Morningstar Developed Markets Dividend Leaders Ucits Etf
GER:VDIVThe Vaneck Morningstar Developed Markets ETF price gained 0.155% on the last trading day (Friday, 19th Jun 2026), rising from 51.70€ to 51.78€. During the last trading day the ETF fluctuated 0.483% from a day low at 51.74€ to a day high of 51.99€. The price has risen in 6 of the last 10 days but is still down by -0.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 36 thousand more shares were traded than the day before. In total, 175 thousand shares were bought and sold for approximately 9.06€ million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The Hensoldt AG stock price gained 1.23% on the last trading day (Friday, 19th Jun 2026), rising from 71.58€ to 72.46€. During the last trading day the stock fluctuated 3.07% from a day low at 71.58€ to a day high of 73.78€. The price has been going up and down for this period, and there has been a -8.02% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 230 thousand more shares were traded than the day before. In total, 516 thousand shares were bought and sold for approximately 37.41€ million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The Carl Zeiss Meditec AG stock price gained 0.403% on the last trading day (Friday, 19th Jun 2026), rising from 24.84€ to 24.94€. During the last trading day the stock fluctuated 2.21% from a day low at 24.48€ to a day high of 25.02€. The price has fallen in 6 of the last 10 days and is down by -6.73% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 31 thousand more shares were traded than the day before. In total, 241 thousand shares were bought and sold for approximately 6.01€ million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Carl Zeiss Meditec AG:
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
The Evotec SE stock price gained 2.03% on the last trading day (Friday, 19th Jun 2026), rising from 4.54€ to 4.63€. During the last trading day the stock fluctuated 2.20% from a day low at 4.54€ to a day high of 4.64€. The price has risen in 5 of the last 10 days but is still down by -6.12% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 108 thousand more shares were traded than the day before. In total, 601 thousand shares were bought and sold for approximately 2.78€ million.
Evotec SE holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Evotec SE:
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
The British American Tobacco p.l.c. stock price fell by -1.41% on the last day (Friday, 19th Jun 2026) from 51.00€ to 50.28€. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.35% from a day low at 50.16€ to a day high of 51.34€. The price has risen in 6 of the last 10 days but is still down by -1.64% for this period. Volume has increased on the last day by 48 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 127 thousand shares were bought and sold for approximately 6.37€ million.
The British American Tobacco p.l.c. stock holds several negative signals and despite the positive trend, we believe British American Tobacco p.l.c. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About British American Tobacco p.l.c.:
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour, tobacco heating, and modern oral nicotine products; combustible products; and traditional oral products, such as snus and moist snuff. The company offers its products under the Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, being Vapour, THP, and Modern Oral brands. It distributes its products to retail outlets. British American Tobacco p.l.c. was incorporated in 1902 and is headquartered in London, the United Kingdom.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
SRPT
$17.02
|
5.52% | Jun 29 |
ROP
$331.60
|
4.54% | Jun 24 |
JLL
$299.78
|
4.87% | Jun 24 |
NESR
$25.07
|
16.83% | Jun 23 |
CAG
$13.43
|
5.36% | Jun 23 |
